Mumps risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 12: Line 12:


*The risk of exposure to mumps among travelers can be high in most countries of the world, especially for travelers who are older than 12 months and who do not have evidence of mumps immunity.  
*The risk of exposure to mumps among travelers can be high in most countries of the world, especially for travelers who are older than 12 months and who do not have evidence of mumps immunity.  
*Working or living in close proximity to an individual infected with Rubulavirus (e.g. classrooms, college dormatories).


*[[Immunodeficiency|Immunodeficieny states]]
*[[Immunodeficiency|Immunodeficieny states]]

Revision as of 16:07, 10 March 2016

Mumps Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Mumps from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mumps risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mumps risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mumps risk factors

CDC on Mumps risk factors

Mumps risk factors in the news

Blogs on Mumps risk factors

Directions to Hospitals Treating Mumps

Risk calculators and risk factors for Mumps risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]; Nate Michalak, B.A.

Overview

Risk Factors

  • Unvaccinated individuals who do not have evidence of immunity.
  • Acceptable presumptive evidence of immunity to mumps includes: documented administration of two doses of live mumps virus vaccine at least 28 days apart, on or after the first birthday; laboratory evidence of immunity; birth before 1957; or documentation of physician-diagnosed mumps.
  • Individuals with only 1 dose of the MMR or MMRV vaccine are at higher risk than those with 2 doses.
  • The risk of exposure to mumps among travelers can be high in most countries of the world, especially for travelers who are older than 12 months and who do not have evidence of mumps immunity.
  • Working or living in close proximity to an individual infected with Rubulavirus (e.g. classrooms, college dormatories).

References


Template:WikiDoc Sources